Research from Sapienza University of Rome in Generalized Epilepsy Provides New Insights (Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy).

Brain Diseases and Conditions, Central Nervous System Agents, Central Nervous System Diseases and Conditions, Drugs and Therapies, Epilepsy, Health and Medicine, Lamotrigine Therapy, Levetiracetam Therapy, Pharmaceuticals, Pyrrolidine Anticonvulsants, Triazine Anticonvulsants, Generalized Epilepsy Keywords: Brain Diseases and Conditions; Central Nervous System Agents; Central Nervous System Diseases and Conditions; Drugs and Therapies; Epilepsy; Generalized Epilepsy; Health and Medicine; Lamotrigine Therapy; Levetiracetam Therapy; Pharmaceuticals; Pyrrolidine Anticonvulsants; Triazine Anticonvulsants EN Brain Diseases and Conditions Central Nervous System Agents Central Nervous System Diseases and Conditions Drugs and Therapies Epilepsy Generalized Epilepsy Health and Medicine Lamotrigine Therapy Levetiracetam Therapy Pharmaceuticals Pyrrolidine Anticonvulsants Triazine Anticonvulsants 1811 1811 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on generalized epilepsy have been published. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)